Is Nexalis Therapeutics Limited overvalued?

Nexalis Therapeutics Limited (NX1.AX) — key valuation metrics and fundamentals.

No verdict

Price

$0.01

Fair value

—

Current P/E

—

Normal P/E

—

Market cap

$2.3M

Dividend yield

—

Return on equity

—

Sector

Healthcare

Fair value compares NX1.AX's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 24 Sep 2026.

Related stocks